7th DIA Cell and Gene Therapy Products Symposium in Japan

概要

7th DIA Cell and Gene Therapy Products Symposium in Japan
“Ten Years Progress of Cell and Gene Therapy Products – Leap forward with our initial passion”

Click Here to View the Japanese Program

Click Here to View the English Program

Featured

Want to learn more about 7th DIA Cell and Gene Therapy Products Symposium in Japan? You've come to the right site!

Exhibits

Sumimasa Nagai, MD, PhD Institute for Advancement of Clinical and Translational Science(iACT)
Kyoto University Hospital, Japan
Ikuo Kawauchi Senior Expert,International Standards Promotion Office,Intellectual Property Div
FUJIFILM Holdings Corporation, Japan
Yoji Sato, PhD Head, Division of Drugs
National Institute of Health Sciences, Japan
Masafumi Onodera, MD, PhD Director, Center of Gene Cell Therapy Promotion,
National Center for Child Health and Development, Japan
Yasuko Terao, PhD Head, External Scientific Engagement, R&D Japan Region,
Takeda Pharmaceutical Co., Ltd., Japan
Hiromi Okabe, PhD Immunology, Regulatory Affairs Japan,Global Drug Development Division
Novartis Pharma K.K, Japan
Teruyo Arato, PhD Professor, Clinical Research and Medical Innovation Center
Hokkaido University Hospital, Japan
Satoru Hayata, MS
Sobi Japan, Japan
Ryutaro Hirasawa CMC Regulatory Affairs, Manager
Daiichi Sankyo Co., Ltd., Japan
Akiko Ikeda, RPh Associate Director, Regulatory Development Dept.
Janssen Pharmaceutical K.K., Japan
Shinichi Noda Deputy Review Director, Office of Cellular and Tissue-based Products
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Kiyoshi Okada, MD, PhD Vice Director, Medical Ctr for Translational Research,Dept of Medical Innovation
Osaka University Hospital, Japan
Hiroyuki Suda, MSc VP, Clinical Development Strategy
KORTUC Inc., Japan
Yoshie Tsurumaki Group Manager, Cell & Gene Franchise
Novartis Pharma K.K., Japan
Keiji Miyamoto Principal Post-Marketing Regulatory Affairs Dep.
Daiichi Sankyo Co.,Ltd., Japan
Akiko Nishioka Clinical Research Associate, Clinical Operation
Novartis Pharma K.K., Japan